Phase 2 Trial of HY209gel in Atopic Dermatitis Patients
Conditions: Atopic Dermatitis; Atopic Dermatitis Eczema; Atopic Dermatitis of Scalp Interventions: Drug: HY209GEL Active; Other: Placebo Sponsor: Shaperon Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials